These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 12124393

  • 21. Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers.
    Bae SI, Lee HS, Kim SH, Kim WH.
    Br J Cancer; 2002 Jun 17; 86(12):1888-92. PubMed ID: 12085181
    [Abstract] [Full Text] [Related]

  • 22. Genome-wide methylation and expression profiling identifies promoter characteristics affecting demethylation-induced gene up-regulation in melanoma.
    Rubinstein JC, Tran N, Ma S, Halaban R, Krauthammer M.
    BMC Med Genomics; 2010 Feb 09; 3():4. PubMed ID: 20144234
    [Abstract] [Full Text] [Related]

  • 23. Progression to metastatic stage in a cellular model of prostate cancer is associated with methylation of the androgen receptor gene and transcriptional suppression of the insulin-like growth factor-I receptor gene.
    Schayek H, Bentov I, Sun S, Plymate SR, Werner H.
    Exp Cell Res; 2010 May 15; 316(9):1479-88. PubMed ID: 20338164
    [Abstract] [Full Text] [Related]

  • 24. Aberrant methylation and silencing of the BNIP3 gene in colorectal and gastric cancer.
    Murai M, Toyota M, Suzuki H, Satoh A, Sasaki Y, Akino K, Ueno M, Takahashi F, Kusano M, Mita H, Yanagihara K, Endo T, Hinoda Y, Tokino T, Imai K.
    Clin Cancer Res; 2005 Feb 01; 11(3):1021-7. PubMed ID: 15709167
    [Abstract] [Full Text] [Related]

  • 25. Identification of hypermethylation in hepatocyte cell adhesion molecule gene promoter region in bladder carcinoma.
    Tao J, Liu Q, Wu X, Xu X, Zhang Y, Wang Q, Luo C.
    Int J Med Sci; 2013 Feb 01; 10(13):1860-7. PubMed ID: 24324362
    [Abstract] [Full Text] [Related]

  • 26. Methylation of specific CpG sites in the promoter region could significantly down-regulate p16(INK4a) expression in gastric adenocarcinoma.
    Song SH, Jong HS, Choi HH, Kang SH, Ryu MH, Kim NK, Kim WH, Bang YJ.
    Int J Cancer; 2000 Jul 15; 87(2):236-40. PubMed ID: 10861481
    [Abstract] [Full Text] [Related]

  • 27. Methylation of a CpG island within the uroplakin Ib promoter: a possible mechanism for loss of uroplakin Ib expression in bladder carcinoma.
    Varga AE, Leonardos L, Jackson P, Marreiros A, Cowled PA.
    Neoplasia; 2004 Jul 15; 6(2):128-35. PubMed ID: 15140401
    [Abstract] [Full Text] [Related]

  • 28. Regulation of the intestinal mucin MUC2 gene expression in vivo: evidence for the role of promoter methylation.
    Gratchev A, Siedow A, Bumke-Vogt C, Hummel M, Foss HD, Hanski ML, Kobalz U, Mann B, Lammert H, Mansmann U, Stein H, Riecken EO, Hanski C.
    Cancer Lett; 2001 Jul 10; 168(1):71-80. PubMed ID: 11368880
    [Abstract] [Full Text] [Related]

  • 29. CpG methylation of promoter region inactivates E-cadherin gene in renal cell carcinoma.
    Nojima D, Nakajima K, Li LC, Franks J, Ribeiro-Filho L, Ishii N, Dahiya R.
    Mol Carcinog; 2001 Sep 10; 32(1):19-27. PubMed ID: 11568972
    [Abstract] [Full Text] [Related]

  • 30. Variable promoter region CpG island methylation of the putative tumor suppressor gene Connexin 26 in breast cancer.
    Tan LW, Bianco T, Dobrovic A.
    Carcinogenesis; 2002 Feb 10; 23(2):231-6. PubMed ID: 11872627
    [Abstract] [Full Text] [Related]

  • 31. Promoter methylation downregulates CDX2 expression in colorectal carcinomas.
    Kawai H, Tomii K, Toyooka S, Yano M, Murakami M, Tsukuda K, Shimizu N.
    Oncol Rep; 2005 Mar 10; 13(3):547-51. PubMed ID: 15706431
    [Abstract] [Full Text] [Related]

  • 32. The 5-lipoxygenase promoter is regulated by DNA methylation.
    Uhl J, Klan N, Rose M, Entian KD, Werz O, Steinhilber D.
    J Biol Chem; 2002 Feb 08; 277(6):4374-9. PubMed ID: 11706027
    [Abstract] [Full Text] [Related]

  • 33. [Expression and Promoter CpG Island Methylation Status of miR-34b in Leukemia Cell Lines and Their Clinical Significance].
    Guo JX, Zhou YH, Guan RT, Pan JX, Zhang XY, Zhong JF.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct 08; 23(5):1235-9. PubMed ID: 26524015
    [Abstract] [Full Text] [Related]

  • 34. Demethylation of the synuclein gamma gene CpG island in primary gastric cancers and gastric cancer cell lines.
    Yanagawa N, Tamura G, Honda T, Endoh M, Nishizuka S, Motoyama T.
    Clin Cancer Res; 2004 Apr 01; 10(7):2447-51. PubMed ID: 15073123
    [Abstract] [Full Text] [Related]

  • 35. Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression.
    Deng G, Chen A, Hong J, Chae HS, Kim YS.
    Cancer Res; 1999 May 01; 59(9):2029-33. PubMed ID: 10232580
    [Abstract] [Full Text] [Related]

  • 36. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
    Gupta A, Godwin AK, Vanderveer L, Lu A, Liu J.
    Cancer Res; 2003 Feb 01; 63(3):664-73. PubMed ID: 12566312
    [Abstract] [Full Text] [Related]

  • 37. Molecular cloning, sequencing and expression of the mRNA encoding human Cdx1 and Cdx2 homeobox. Down-regulation of Cdx1 and Cdx2 mRNA expression during colorectal carcinogenesis.
    Mallo GV, Rechreche H, Frigerio JM, Rocha D, Zweibaum A, Lacasa M, Jordan BR, Dusetti NJ, Dagorn JC, Iovanna JL.
    Int J Cancer; 1997 Feb 20; 74(1):35-44. PubMed ID: 9036867
    [Abstract] [Full Text] [Related]

  • 38. Promoter hypomethylation of a novel cancer/testis antigen gene CAGE is correlated with its aberrant expression and is seen in premalignant stage of gastric carcinoma.
    Cho B, Lee H, Jeong S, Bang YJ, Lee HJ, Hwang KS, Kim HY, Lee YS, Kang GH, Jeoung DI.
    Biochem Biophys Res Commun; 2003 Jul 18; 307(1):52-63. PubMed ID: 12849980
    [Abstract] [Full Text] [Related]

  • 39. The expression of metastasis suppressor MIM/MTSS1 is regulated by DNA methylation.
    Utikal J, Gratchev A, Muller-Molinet I, Oerther S, Kzhyshkowska J, Arens N, Grobholz R, Kannookadan S, Goerdt S.
    Int J Cancer; 2006 Nov 15; 119(10):2287-93. PubMed ID: 16921485
    [Abstract] [Full Text] [Related]

  • 40. Semaphorin-3F functions as a tumor suppressor in colorectal cancer due to regulation by DNA methylation.
    Gao X, Tang C, Shi W, Feng S, Qin W, Jiang T, Sun Y.
    Int J Clin Exp Pathol; 2015 Nov 15; 8(10):12766-74. PubMed ID: 26722466
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.